MedTrace Logo

Diabetes, Exercise and Liver Fat (DELIVER)

NCT04004273 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-10-05

No results posted yet for this study

Summary

This randomised controlled trial will determine if exercise (150 - 200 min per week, 6 weeks) can beneficially modify liver fat quality in non alcohol fatty liver disease patients with type 2 diabetes mellitus (n = 26, 13 per group). Liver fat quality will be assessed via magnetic resonance (3T) spectroscopy (1H-MRS) using validated methods.

Conditions

Interventions

BEHAVIORAL

Exercise

24 moderate-intensity exercise training sessions over six weeks (four times per week; \~50 min per session)

Sponsors & Collaborators

  • University Hospitals, Leicester

    collaborator OTHER

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • University of Nottingham

    collaborator OTHER

  • James King

    lead OTHER

Principal Investigators

  • James A King, PhD · Loughborough University

  • Guruprasad P Aithal, PhD · Nottingham Biomedical Research Centre

  • David Webb, PhD · Leicester Diabetes Research Centre

  • Penny Gowland, PhD · Sir Peter Mansfield Imaging Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2022-07-20
Completion
2022-07-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04004273 on ClinicalTrials.gov